Home › Is Exact Sciences Poised For A Monopoly On Colon Cancer Screening?
 

Keywords :   


Is Exact Sciences Poised For A Monopoly On Colon Cancer Screening?

2015-02-18 11:29:09| Biotech - Topix.net

There will be around 130,000 new cases of colorectal cancer and close to 50,000 deaths due to colorectal cancer in the U.S. in 2015 alone. Cologuard from Exact Sciences is FDA approved and has a screening detection rate of 93% compared to closest competitor at 73%.

Tags: exact sciences cancer screening

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05ABG announces leadership transition
16.05CeraVe Expands Sun Safety Day Initiative to Offer SPF Education Across the US this Summer
16.05Ex-Post Office IT boss blocked Vennells' number
16.05Covergirls New Eye Enhancer 3D Mascara Makes Eyes Pop
16.05ANEX to be Held in Taiwan Next Week
16.05Reality TV stars charged over investment plugs
16.05HCPA Announces EPR Webinar Series
16.05NatureWorks Receives Funding for Thailand Investment
More »